Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders

Table 2

Logistic regression model of variables associated with conversion to dementia in the MCI cohort.

	OR	2.50%	97.50%	value
(Intercept)	0.0014	1.00E − 04	0.029	<0.001
VaD	2.082	0.910	4.909	0.089
LBD	0.536	0.225	1.223	0.146
Age	1.071	1.032	1.113	<0.001
Gender	0.540	0.293	0.980	0.044
CDR-SB	1.553	1.221	2.008	<0.001
Hyperlipidemia	0.554	0.310	0.980	0.044
Depression	1.624	0.730	3.623	0.233
Antidementia agents	5.162	2.663	10.522	<0.001
Hypnotic agents	1.346	0.719	2.517	0.352

VaD: vascular dementia; LBD: Lewy body diseases; CDR-SB: Clinical Dementia Rating-Sum of Boxes. Remark: antidementia agents: acetylcholinesterase inhibitors and memantine. Hypnotic agents: benzodiazepines and nonbenzodiazepine hypnotic agents.